カテゴリ： Grand View Research, 世界, 医療/バイオ

医療食品の世界市場：投与経路別（経口、経腸）、製品別（錠剤、粉末）、用途別、販売経路別（オンライン、機関、小売）

◆英語タイトル：Medical Foods Market Size, Share & Trends Analysis Report By Route of Administration (Oral, Enteral), By Product (Pills, Powder), By Application, By Sales Channel (Online, Institutional, Retail), And Segment Forecasts, 2020 - 2027
◆商品コード：GV20MY057
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2020年3月3日
◆ページ数：120
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥939,750見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、医療食品の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、投与経路別（経口、経腸）分析、製品別（錠剤、粉末、その他）分析、用途別（慢性腎臓病、最小肝性脳症、化学療法誘発下痢、病原体関連感染症、糖尿病性神経障害、ADHD、うつ病、アルツハイマー病、栄養欠乏症、孤児病、その他）分析、地域別分析、企業概要などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・競争分析
・医療食品の世界市場：投与経路別（経口、経腸）
・医療食品の世界市場：製品別（錠剤、粉末、その他）
・医療食品の世界市場：用途別（慢性腎臓病、最小肝性脳症、化学療法誘発下痢、病原体関連感染症、糖尿病性神経障害、ADHD、うつ病、アルツハイマー病、栄養欠乏症、孤児病、その他）
・医療食品の世界市場：地域別
・企業概要
【レポートの概要】

The global medical foods market size is expected to reach USD 30.4 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% over the forecast period. This market is driven by rising geriatric population, increasing prevalence of chronic diseases, and growing focus of policymakers on the management of malnutrition. Dietary management of chronic diseases and rare disorders is the emerging focus area for manufacturers of medical foods, which is also positively impacting the market growth. Patients with chronic diseases develop nutritional deficiencies owing to adverse effects of the disease or the drugs that are used for treatment. Medical foods address these nutritional deficiencies, further driving their consumption.

Moreover, rising prevalence of chronic diseases requiring nutritional management of patients is a key factor which is expected to drive the market growth. According to WHO Noncommunicable Diseases Progress Monitor (2017), chronic diseases such as cancer, diabetes, and cardiovascular diseases are among the leading causes of death globally, accounting for nearly 70.0% of the deaths worldwide. According to Milken Institute, the economic burden of chronic diseases in U.S. was estimated to be USD 1.1 trillion in 2016. A constant rise has been observed in the prevalence of chronic diseases such as Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), osteoporosis, osteoarthritis, and central nervous system disorders, which require clinical dietary management. Medical foods, also known as foods for special medical purposes, are intended for the dietary management of patients with impaired or limited capacity to digest, ingest, absorb, and metabolize a normal diet and for patients with special nutrient requirements.

Diabetic neuropathy emerged as the largest application segment in 2019 owing to the increase in prevalence of diabetes and rise in the number of patients that are at risk of developing some level of neuropathy. Various initiatives are being undertaken for dietary management of diabetes and are among the key market drivers. However, the chronic kidney diseases segment is expected to witness the highest growth rate over the forecast period.

Further key findings from the report suggest:

• Orally administered medical foods held the largest share in 2019 due to ease in administration along with high commercial availability

• Diabetic neuropathy emerged as the leading application segment in 2019; however, chronic kidney disorder is expected to register the highest growth rate over the forecast period owing to the rising prevalence of chronic diseases such as cardiovascular diseases and cancer

• Asia Pacific dominated the global market in 2019 due to the presence of several target diseases cases such as obesity and malnutrition in the region

• Key players operating in the medical foods market include Danone S.A., Abbott Laboratories, Nestle S.A., Mead Johnsons & Company, LLC, and Fresenius Kabi.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Medical Foods Snapshot
Chapter 3 Global Medical Foods Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2. Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Perspective Analysis
3.4.1 Consumer behavior analysis
3.4.2 Market influencer analysis
3.5 Technology Outlook
3.5.1 Technology timeline
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards and compliances
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.2 Market restraint analysis
3.7.3. Industry Challenges
3.8 Medical Foods Market Analysis Tools
3.8.1. Industry analysis – Porter’s
3.8.1.1 Supplier power
3.8.1.2 Buyer power
3.8.1.3 Substitution threat
3.8.1.4 Threat from new entrant
3.8.1.5 Competitive rivalry
3.8.2. PESTEL analysis
3.8.2.1 Political landscape
3.8.2.2 Environmental landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal landscape
3.8.2.6 Economic landscape
3.8.3 Major deals & strategic alliances analysis
3.8.3.1 Mergers & acquisitions
3.8.3.2 Licensing & partnership
3.8.4 Market entry strategies
Chapter 4 Medical Foods Market-Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Competition Categorization
4.3 Vendor Landscape
4.3.1 List of Key Distributors and Channel Partners
4.3.2 Key Company Market Share Analysis, 2018/2019
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Ranking, By Region
4.5 Private Companies
4.5.1 Regional Network Map
4.5.2 Company Market Position Analysis
Chapter 5 Medical Foods Market: Route of Administration Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Medical Foods Market: Route of Administration Market Share Analysis, 2019 and 2027
5.3 Oral
5.3.1 Oral market estimates and forecasts, 2016 – 2027 (USD million)
5.4 Enteral
5.4.1 Enteral market estimates and forecasts, 2016 – 2027 (USD million)
Chapter 6 Medical Foods Market: Product Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Global Medical Foods Market: Product Market Share Analysis, 2019 and 2027
6.3 Pills
6.3.1 Pills market estimates and forecasts, 2016 – 2027 (USD million)
6.4 Powder
6.4.1 Powder market estimates and forecasts, 2016 – 2027 (USD million)
6.5 Others
6.5.1 Others market estimates and forecasts, 2016 – 2027 (USD million)
Chapter 7 Medical Foods Market: Application Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Global Medical Foods Market: Application Market Share Analysis, 2019 and 2027
7.3 Chronic kidney diseases
7.3.1 Chronic kidney diseases market estimates and forecasts, 2016 – 2027 (USD million)
7.4 Minimal hepatic encephalopathy
7.4.1 Minimal hepatic encephalopathy market estimates and forecasts, 2016 – 2027 (USD million)
7.5 Chemotherapy induced diarrhea
7.5.1 Chemotherapy induced diarrhea market estimates and forecasts, 2016 – 2027 (USD million)
7.6 Pathogen related infections
7.6.1 Pathogen related infections market estimates and forecasts, 2016 – 2027 (USD million)
7.7 Diabetic neuropathy
7.7.1 Diabetic neuropathy market estimates and forecasts, 2016 – 2027 (USD million)
7.8 ADHD
7.8.1 ADHD market estimates and forecasts, 2016 – 2027 (USD million)
7.9 Depression
7.9.1 Depression market estimates and forecasts, 2016 – 2027 (USD million)
7.10 Alzheimer’s disease
7.10.1 Alzheimer’s disease market estimates and forecasts, 2016 – 2027 (USD million)
7.11 Nutritional deficiency
7.11.1 Nutritional deficiency market estimates and forecasts, 2016 – 2027 (USD million)
7.12 Orphan diseases
7.12.1 Orphan diseases market estimates and forecasts, 2016 – 2027 (USD million)
7.12.2 Phenylketonuria
7.12.2.1 Phenylketonuria market estimates and forecasts, 2016 – 2027 (USD million)
7.12.3 Eosinophilic esophagitis
7.12.3.1 Eosinophilic esophagitis market estimates and forecasts, 2016 – 2027 (USD million)
7.12.4 FPIES
7.12.4.1 FPIES market estimates and forecasts, 2016 – 2027 (USD million)
7.12.5 Others
7.12.5.1 Others market estimates and forecasts, 2016 – 2027 (USD million)
7.13 Other applications
7.13.1 Other applications market estimates and forecasts, 2016 – 2027 (USD million)
Chapter 8 Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Global Medical Foods Market: Sales Channel Market Share Analysis, 2019 and 2027
8.3 Online sales
8.3.1 Online sales market estimates and forecasts, 2016 – 2027 (USD million)
8.4 Institutional sales
8.4.1 Institutional sales market estimates and forecasts, 2016 – 2027 (USD million)
8.5 Retail sales
8.5.1 Retail sales market estimates and forecasts, 2016 – 2027 (USD million)
Chapter 9 Medical Foods Market: Regional Estimates & Trend Analysis, By Route of Administration, Product, Application, and Sales Channel
9.1 Global Medical Foods Market: Regional Movement Analysis
9.2 North America
9.2.1 Market estimates and forecasts by administration, Product, application, and sales channel, 2016 – 2027 (USD Million)
9.2.2 U.S.
9.2.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.2.3 Canada
9.2.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.3 Europe
9.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.3.2 U.K.
9.3.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.3.3 Germany
9.3.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.3.4 France
9.3.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.3.5 Spain
9.3.5.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.3.6 Italy
9.3.6.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.3.7 Russia
9.3.7.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4 Asia Pacific
9.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4.2 China
9.4.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4.3 Japan
9.4.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4.4 India
9.4.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4.5 Australia
9.4.5.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4.6 New Zealand
9.4.6.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4.7 Singapore
9.4.7.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.4.8 South Korea
9.4.8.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.5 Latin America
9.5.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.5.2 Brazil
9.5.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.5.3 Mexico
9.5.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.5.4 Argentina
9.5.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.6 MEA
9.6.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.6.2 South Africa
9.6.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
9.6.4 UAE
9.6.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 – 2027 (USD Million)
Chapter 10 Company Profiles
10.1 DANONE
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 NESTLÉ
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 ABBOTT
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 TARGETED MEDICAL PHARMA INC.
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 PRIMUS PHARMACEUTICALS, INC.
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 MEAD JOHNSON & COMPANY, LLC
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 FRESENIUS KABI AG
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 List of Other Companies

List of Tables

TABLE 1 Global Electronic Contract Manufacturing and Design Services market, 2016 - 2027 (USD Billion)
TABLE 2 Global Electronic Contract Manufacturing and Design Services market, by service, 2016 - 2027 (USD Billion)
TABLE 3 Global Electronic Contract Manufacturing and Design Services market, by end use, 2016 - 2027 (USD Billion)
TABLE 4 Global Electronic Contract Manufacturing and Design Services market, by region, 2016 - 2027 (USD Billion)
TABLE 5 Electronic design & engineering market, 2016 - 2027 (USD Billion)
TABLE 6 Electronic design & engineering market, by region, 2016 - 2027 (USD Billion)
TABLE 7 Electronics assembly market, 2016 - 2027 (USD Billion)
TABLE 8 Electronics assembly market, by region, 2016 - 2027 (USD Billion)
TABLE 9 Electronic manufacturing market, 2016 - 2027 (USD Billion)
TABLE 10 Electronic manufacturing market, by region, 2016 - 2027 (USD Billion)
TABLE 11 Other services market, 2016 - 2027 (USD Billion)
TABLE 12 Other services market, by region, 2016 - 2027 (USD Billion)
TABLE 13 Electronic contract manufacturing and design services demand in healthcare sector, 2016 - 2027 (USD Billion)
TABLE 14 Electronic contract manufacturing and design services demand in healthcare sector, by region, 2016 - 2027 (USD Billion)
TABLE 15 Electronic contract manufacturing and design services demand in automotive sector, 2016 - 2027 (USD Billion)
TABLE 16 Electronic contract manufacturing and design services demand in automotive sector, by region, 2016 - 2027 (USD Billion)
TABLE 17 Electronic contract manufacturing and design services demand in industrial sector, 2016 - 2027 (USD Billion)
TABLE 18 Electronic contract manufacturing and design services demand in industrial sector, by region, 2016 - 2027 (USD Billion)
TABLE 19 Electronic contract manufacturing and design services demand in aerospace & defense sector, 2016 - 2027 (USD Billion)
TABLE 20 Electronic contract manufacturing and design services demand in aerospace & defense sector, by region, 2016 - 2027 (USD Billion)
TABLE 21 Electronic contract manufacturing and design services demand in IT & telecom sector, 2016 - 2027 (USD Billion)
TABLE 22 Electronic contract manufacturing and design services demand in IT & telecom sector, by region, 2016 - 2027 (USD Billion)
TABLE 23 Electronic contract manufacturing and design services demand in power & energy sector, 2016 - 2027 (USD Billion)
TABLE 24 Electronic contract manufacturing and design services demand in power & energy sector, by region, 2016 - 2027 (USD Billion)
TABLE 25 Electronic contract manufacturing and design services demand in consumer electronics, 2016 - 2027 (USD Billion)
TABLE 26 Electronic contract manufacturing and design services demand in consumer electronics, by region, 2016 - 2027 (USD Billion)
TABLE 27 Electronic contract manufacturing and design services demand in other end-use industries, 2016 - 2027 (USD Billion)
TABLE 28 Electronic contract manufacturing and design services demand in other end-use industries, by region, 2016 - 2027 (USD Billion)
TABLE 29 North America electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 30 North America electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 31 U.S. electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 32 U.S. electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 33 Canada electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 34 Canada electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 35 Mexico electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 36 Mexico electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 37 Europe electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 38 Europe electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 39 U.K. electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 40 U.K. electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 41 Germany electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 42 Germany electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 43 Asia Pacific electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 44 Asia Pacific electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 45 China electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 46 China electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 47 India electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 48 India electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 49 Japan electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 50 Japan electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 51 South America electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 52 South America electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 53 Brazil electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 54 Brazil electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)
TABLE 55 Middle East & Africa electronic contract manufacturing and design services market by service, 2016 - 2027 (USD Billion)
TABLE 56 Middle East & Africa electronic contract manufacturing and design services market by end use, 2016 - 2027 (USD Billion)

List of Figures

FIG. 1 Research process
FIG. 2 Information procurement
FIG. 3 Regional Key Takeaways
FIG. 4 Global electronic contract manufacturing and design services - Market segmentation & scope
FIG. 5 Global electronic contract manufacturing and design services - Market size and growth prospects (USD Billion)
FIG. 6 Global electronic contract manufacturing and deisgn services - Value chain analysis
FIG. 7 Global electronic contract manufacturing and design services - Market dynamics
FIG. 8 Global electronic contract manufacturing and deisgn services - Market driver relevance analysis (Current & future impact)
FIG. 9 Global electronic contract manufacturing and deisgn services - Market restraint/challenge relevance analysis (Current & future impact)
FIG. 10 Global electronic contract manufacturing and design services - Market opportunity relevance analysis (Current & future impact)
FIG. 11 Global electronic contract manufacturing and design services - Penetration & growth prospect mapping
FIG. 12 Electronic Contract Manufacturing and design Services - Porter’s analysis
FIG. 13 Global electronic contract manufacturing and design services - PEST analysis
FIG. 14 Global electronic contract manufacturing and design services outlook, 2019 & 2027
FIG. 15 Global electronic contract manufacturing and design services end-use outlook, 2019 & 2027
FIG. 16 Global electronic contract manufacturing and design services regional outlook, 2019 & 2027
FIG. 17 Benchmark Electronics, Inc.
FIG. 18 Celestica, Inc.
FIG. 19 Compal Electronics, Inc.
FIG. 20 Creation Technologies LP
FIG. 21 Fabrinet
FIG. 22 Flex LTD.
FIG. 23 Hon Hai Precision Industry Co. Ltd.
FIG. 24 Jabil Circuit, Inc.
FIG. 25 Plexus Corporation
FIG. 26 Sanmina Corporation
FIG. 27 Venture Corporation Limited

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[医療食品の世界市場：投与経路別（経口、経腸）、製品別（錠剤、粉末）、用途別、販売経路別（オンライン、機関、小売）]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 消費者医療の世界市場：種類別（OTC医薬品、栄養補助食品）、用途別（病院、小売、オンライン）、地域別
    BZW20AP040 / Bizwit Research & Consulting / 2020年4月22日 / 本調査レポートでは、消費者医療の世界市場について、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、種類別（OTC医薬品、栄養補助食品）分析、用途別（病院、小売、オンライン）分析、地域別分析、競争状況などを総合的、多面的に調査・分析しております。 ・エグゼクティブサマリー ・市場の定義・範囲 ・市場動向 ・産業分析 ・消費者医療の世界市場：種類別（OTC医薬品、栄養補助食品） ・消費者医療の世界市場：用途別（病院、小売、オンライン） ・消費者医療の世界市場：地域別 ・競争状況...Global Consumer Healthcare Market is valued approximately at USD XXX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2019-2026. Consumer healthcare are the products that aid in wellness, oral health, nutrition and skin health. These are mainly over the counter drugs which are sold directly to the consumer without the prescription from a healthcare professional. The major factors that contribute towards the growth of the market are high demand for self-medication coupled with rising health awareness. As the concerns regarding health increases, the inclination of people...
  2. ホルモン補充療法の世界市場：製品別（エストロゲン、人間成長）、投与経路別（経口、非経口）、疾患種類別、地域別
    GV20MY053 / Grand View Research / 2020年2月17日 / 本調査レポートでは、ホルモン補充療法の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別（エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法）分析、投与経路別（経口、非経口、経皮、その他）分析、疾患種類別（更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他）分析、地域別分析、競争分析などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・ホルモン補充療法の世界市場：製品別（エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法） ・ホルモン補充療法の世界市場：投与経路別（経口、非経口、経皮、その他） ・ホルモン補充療法の世界市場：疾患種類別（更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他） ・ホルモン補充療法の世界市場：地域別 ・競争分析...The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy. Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill,...
  3. デジタル治療学の世界市場：用途別（糖尿病、肥満、心血管疾患（CVD）、中枢神経系（CNS）疾患、呼吸器疾患、禁煙、胃腸障害（GID）、その他）、製品種類別（ソフトウェア、デバイス）、販売経路別（B2B、B2C）
    AMR20MY0125 / Allied Market Research / 2020年1月 / 本調査レポートでは、デジタル治療学の世界市場について調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、用途別（糖尿病、肥満、心血管疾患（CVD）、中枢神経系（CNS）疾患、呼吸器疾患、禁煙、胃腸障害（GID）、その他）分析、製品種類別（ソフトウェア、デバイス）分析、販売経路別（B2B、B2C）分析、地域別分析、企業概要などを含め、今後の方向性を明らかに致します。 ・イントロダクション ・エグゼクティブサマリ－ ・市場概要 ・デジタル治療学の世界市場：用途別（糖尿病、肥満、心血管疾患（CVD）、中枢神経系（CNS）疾患、呼吸器疾患、禁煙、胃腸障害（GID）、その他） ・デジタル治療学の世界市場：製品種類別（ソフトウェア、デバイス） ・デジタル治療学の世界市場：販売経路別（B2B、B2C） ・デジタル治療学の世界市場：地域別 ・企業概要...The global digital therapeutics market was valued at $2,238 million in 2018 and is expected to reach $9,640 million by 2026 with a CAGR of 19.9% during the forecast period. Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and...
  4. ドラッグデリバリーデバイスの世界市場2020-2027：用途別、投与経路別、最終用途別、車両別、地域別
    GV20JN106 / Grand View Research / 2020年4月 / 本調査レポートでは、ドラッグデリバリーデバイスの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、投与経路別（口腔、吸入、経皮、注射剤、眼球、その他）分析、用途別分析、最終用途別分析、車両別分析、地域別分析、競争状況など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・ドラッグデリバリーデバイスの世界市場規模：投与経路別（口腔、吸入、経皮、注射剤、眼球、その他） ・ドラッグデリバリーデバイスの世界市場規模：用途別 ・ドラッグデリバリーデバイスの世界市場規模：最終用途別 ・ドラッグデリバリーデバイスの世界市場規模：車両別 ・ドラッグデリバリーデバイスの世界市場規模：地域別 ・競争状況...The global drug delivery devices market size is expected to reach USD 354.8 billion by 2027, expanding at a CAGR of 6.15% over the forecast period, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to...
  5. 眼科用医薬品の世界市場：薬物クラス別、疾患別、剤形別、投与経路別、製品タイプ別、地域別
    GV20MY062 / Grand View Research / 2020年2月18日 / 本調査レポートでは、眼科用医薬品の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、薬物クラス別（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障、その他）分析、疾患別（ドライアイ、眼アレルギー、緑内障、眼感染症、網膜疾患、ブドウ膜炎）分析、剤形別（ゲル、点眼液、カプセル剤、錠剤、点眼剤、軟膏）分析、投与経路別分析、製品種類別（処方薬、OTC薬）分析、地域別分析、企業概要などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・競争分析 ・眼科用医薬品の世界市場：薬物クラス別（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障、その他） ・眼科用医薬品の世界市場：疾患別（ドライアイ、眼アレルギー、緑内障、眼感染症、網膜疾患、ブドウ膜炎） ・眼科用医薬品の世界市場：剤形別（ゲル、点眼液、カプセル剤、錠剤、点眼剤、軟膏） ・眼科用医薬品の世界市場：投与経路別 ・眼科用医薬品の世界市場：製品種類別（処方薬、OTC薬）...The global ophthalmic drugs market size is expected to reach USD 45.8 billion by 2027, registering a CAGR of 5.0%, according to a new report published by Grand View Research, Inc. Advancements in drug delivery systems are anticipated to drive the overall growth. In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis. Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic...
  6. アンドロゲン欠乏療法（ADT）の世界市場：薬物クラス別（抗アンドロゲン、LHRHアゴニスト、LHRH拮抗薬、その他）、投与経路別（経口、注射）、流通経路別（病院、小売薬局、オンライン薬局）、地域別
    BZW20AP030 / Bizwit Research & Consulting / 2020年2月6日 / 本調査レポートでは、アンドロゲン欠乏療法（ADT）の世界市場について、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、薬物クラス別（抗アンドロゲン、LHRHアゴニスト、LHRH拮抗薬、その他）分析、投与経路別（経口、注射）分析、流通経路別（病院、小売薬局、オンライン薬局）分析、地域別分析、競争状況などを総合的、多面的に調査・分析しております。 ・エグゼクティブサマリー ・市場の定義・範囲 ・市場動向 ・産業分析 ・アンドロゲン欠乏療法（ADT）の世界市場：薬物クラス別（抗アンドロゲン、LHRHアゴニスト、LHRH拮抗薬、その他） ・アンドロゲン欠乏療法（ADT）の世界市場：投与経路別（経口、注射） ・アンドロゲン欠乏療法（ADT）の世界市場：流通経路別（病院、小売薬局、オンライン薬局） ・アンドロゲン欠乏療法（ADT）の世界市場：地域別 ・競争状況...Global Androgen Deprivation Therapy (ADT) Market is valued approximately at USD XX billion in 2018 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. Androgen deprivation therapy (ADT) is a type of antihormone therapy which is primarily utilized in the cure of prostate cancer. Prostate cancer cells typically requires androgen hormones such as testosterone to grow. The use of androgen deprivation therapy reduces the level of androgen hormones, with surgery or drug delivery to prevent the prostate cells from rising. Various studies have determined that ADT has shown the benefits...
  7. パラセタモールの世界市場2020-2026：形態別（錠剤、液体懸濁液、カプセル、その他）、投与経路別、地域別
    BZW20JN001 / Bizwit Research & Consulting / 2020年5月25日 / 本調査レポートでは、パラセタモールの世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、形態別（錠剤、液体懸濁液、カプセル、その他）分析、投与経路別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向 ・産業分析 ・パラセタモールの世界市場：形態別（錠剤、液体懸濁液、カプセル、その他） ・パラセタモールの世界市場：投与経路別 ・パラセタモールの世界市場：地域別 ・競争状況...Global Paracetamol Market is valued approximately at USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. Paracetamol, also known as acetaminophen, is an important ingredient in hundreds of prescriptions and over the counter (OTC) drugs and in drugs, it is also combined with other active ingredients to cure asthma, cough, colds, flu and sleeplessness. The appetite for acetaminophen is driven by the growing prevalence of neurological diseases and pain-management conditions. It is still commonly available in many countries as an over the counter drug and...
  8. 嚢胞性線維症の治療薬の世界市場：クラス別（膵臓酵素サプリメント、粘液溶解薬、気管支拡張薬、CFTR調整剤）、投与経路別（経口薬、吸入薬）、地域別予測
    BZW8D79 / Bizwit Research & Consulting / 2018年11月 / 本資料は、嚢胞性線維症の治療薬の世界市場について調べ、嚢胞性線維症の治療薬の世界規模、市場動向、市場環境、クラス別（膵臓酵素サプリメント、粘液溶解薬、気管支拡張薬、CFTR調整剤）分析、投与経路別（経口薬、吸入薬）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはAbbvie、F. Hoffmann-La Roche Ltd.、Gilead、Vertex Pharmaceuticals Inc.、Alaxiaなどです。 ・イントロダクション ・エグゼクティブサマリー ・嚢胞性線維症の治療薬の世界市場概要 ・嚢胞性線維症の治療薬の世界市場環境...Global Cystic Fibrosis Therapeutics Market to reach USD XX billion by 2025. Global Cystic Fibrosis Therapeutics Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major driving factor of global cystic fibrosis therapeutics market are rising prevalence of cystic fibrosis, rising awareness about cystic fibrosis therapy, technological advancement and high rate of Research & Development initiatives. The growing strategic collaboration is one of the key trends contributing towards the growth of the cystic fibrosis (CF) therapeutics market. The major restraining factors of...
  9. 麻酔薬の世界市場：タイプ別（全身麻酔、脊椎麻酔、末梢神経ブロック、サドルブロック麻酔、斜角筋間ブロック、IV局所麻酔）、投与経路別（注射、吸入）、製品別（プロポフォール、セボフルラン、デスフルラン、レミフェンタニル、ミダゾラム、デクスメデトミジン、その他）、地域別予測
    BZW8D76 / Bizwit Research & Consulting / 2018年11月 / 本資料は、麻酔薬の世界市場について調べ、麻酔薬の世界規模、市場動向、市場環境、タイプ別（全身麻酔、脊椎麻酔、末梢神経ブロック、サドルブロック麻酔、斜角筋間ブロック、IV局所麻酔）分析、投与経路別（注射、吸入）分析、製品別（プロポフォール、セボフルラン、デスフルラン、レミフェンタニル、ミダゾラム、デクスメデトミジン、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはAstra Zeneca、Abott Laboratories、Baxter International Inc、Boehringer Ingelheim、Eisai Co Ltd、Fresenius SE &...Global Anesthesia Drug Market to reach USD xxx billion by 2025. Global Anesthesia Drug Market valued approximately USD xxx billion in 2017 is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2018-2025. The Anesthesia defined as the temporary condition of unconsciousness, loss of memory, lack of pain and muscle relaxation. In the medical terms the anesthesia has taken its pivotal place in the treatment of diseases and surgeries. In the present scenario, the rising aging population and enhancing medical utility of anesthesia drugs in the medical care and surgeries is anticipated to...
  10. 新型コロナウイルス感染症の影響による胃がん治療薬の世界市場2020-2026：投与経路別（経口、非経口）、化学療法別、分子種類別、地域別
    BZW20JN001 / Bizwit Research & Consulting / 2020年5月25日 / 本調査レポートでは、新型コロナウイルス感染症の影響による胃がん治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、投与経路別（経口、非経口）分析、化学療法別分析、分子種類別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向 ・産業分析 ・新型コロナウイルス感染症の影響による胃がん治療薬の世界市場：投与経路別（経口、非経口） ・新型コロナウイルス感染症の影響による胃がん治療薬の世界市場：化学療法別 ・新型コロナウイルス感染症の影響による胃がん治療薬の世界市場：分子種類別 ・新型コロナウイルス感染症の影響による胃がん治療薬の世界市場：地域別 ・競争状況...Global Gastric Cancer Drugs Market is valued approximately USD 3.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 15.5% over the forecast period 2020-2026. Gastric cancer, also known as stomach cancer, which is characterized by an intensification of cancerous cells within the lining of the stomach. This type of cancer is usually complex to identify because in most people it normally does not show symptoms at the earlier stages. While, gastric cancer is quite rare as compared to other forms of cancer. There are some other factors of gastric cancer that include...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆